Trimonil Retard 300 mg Norveška - norveški - Statens legemiddelverk

trimonil retard 300 mg

orifarm as - karbamazepin - depottablett - 300 mg

Trimonil Retard 300 mg Norveška - norveški - Statens legemiddelverk

trimonil retard 300 mg

orifarm as - karbamazepin - depottablett - 300 mg

Valaciclovir Sandoz 500 mg Norveška - norveški - Statens legemiddelverk

valaciclovir sandoz 500 mg

sandoz a/s - valaciklovirhydroklorid - tablett, filmdrasjert - 500 mg

Valaciclovir Sandoz 250 mg Norveška - norveški - Statens legemiddelverk

valaciclovir sandoz 250 mg

sandoz a/s - valaciklovirhydroklorid - tablett, filmdrasjert - 250 mg

Valtrex 250 mg Norveška - norveški - Statens legemiddelverk

valtrex 250 mg

glaxosmithkline as - valaciklovirhydroklorid - tablett, filmdrasjert - 250 mg

Valtrex 500 mg Norveška - norveški - Statens legemiddelverk

valtrex 500 mg

glaxosmithkline as - valaciklovirhydroklorid - tablett, filmdrasjert - 500 mg

Duzallo Europska Unija - norveški - EMA (European Medicines Agency)

duzallo

grunenthal gmbh - allopurinol, lesinurad - gikt - antigout preparater - duzallo er angitt i voksne for behandling av hyperuricaemia i gikt pasienter som ikke har oppnådd målet serum urinsyre med en tilstrekkelig dose av allopurinol alene.

Ontozry Europska Unija - norveški - EMA (European Medicines Agency)

ontozry

angelini pharma s.p.a - cenobamate - epilepsi - antiepileptics, - adjunctive treatment of focal-onset seizures with or without secondary generalisation in adult patients with epilepsy who have not been adequately controlled despite a history of treatment with at least 2 anti-epileptic medicinal products.

Pirfenidone axunio (previously Pirfenidone AET) Europska Unija - norveški - EMA (European Medicines Agency)

pirfenidone axunio (previously pirfenidone aet)

axunio pharma gmbh - pirfenidone - idiopatisk lungefibrose - immunsuppressive - pirfenidone aet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Axura Europska Unija - norveški - EMA (European Medicines Agency)

axura

merz pharmaceuticals gmbh - memantinhydroklorid - alzheimers sykdom - andre anti-demens medisiner - behandling av pasienter med moderat til alvorlig alzheimers sykdom.